Navigation Links
Women Health Care Executives Names Genomic Health President Kimberly Popovits as 'Woman of the Year'
Date:3/3/2008

Popovits to be Honored at Gala Dinner in San Francisco on June 12, 2008

SAN FRANCISCO and REDWOOD CITY, Calif., Mar. 3 /PRNewswire/ -- Women Health Care Executives of Northern California (WHCE) announced today that Kimberly Popovits, president and chief operating officer of Redwood City-based Genomic Health, Inc., has been named its 2008 "Woman of the Year." Popovits will be honored at a gala dinner to be held at the Carnelian Room atop the Bank of America building in San Francisco on June 12, 2008.

"The WHCE board of directors always has many impressive candidates to choose from, and this year was no exception," said WHCE President Kimberly Werninghaus Blair. "But Kim Popovits' professional accomplishments, the many people and lives she has impacted, and the contributions her work has made to the larger medical and biopharmaceutical communities gave us a clear choice for our 2008 Woman of the Year."

Popovits has been a leader in the biopharmaceutical industry for more than 25 years. She spent 15 years as head of commercial operations at Genentech, where she led the successful commercialization of 14 new therapies, including Herceptin(R), the cancer treatment drug that revolutionized the way doctors treat a particularly aggressive form of breast cancer. Herceptin is often touted as the first "targeted therapy," that is, one based on an individual's unique genetic profile, and that it has helped to usher in the age of "personalized medicine." As Genomic Health's president and chief operating officer, Popovits helped bring yet another first-of-its-kind product to women: the Oncotype(R) DX breast cancer test, which predicts whether a woman's cancer will return and how likely she is to benefit from chemotherapy based on the genomic makeup of her tumor. Thanks to her pioneering mentality and perseverance with physicians and payers, more than 46,000 women to date have benefited from the individualized information that Oncotype DX provides in making their personal breast cancer treatment decisions.

"We're pleased and proud that a society dedicated to advancing women's careers in health care has recognized Kim as its 2008 Woman of the Year," said Randy Scott, Ph.D., chairman and CEO of Genomic Health. "Kim is a passionate and accomplished leader who consistently puts the needs of patients first, while inspiring women in our company and throughout the health care industry. She truly is a role model for us all."

Women Health Care Executives of Northern California (WHCE) is a dynamic community of women health care professionals in the Bay Area, who encourage and inspire each other throughout the development of their careers. For more information about WHCE and Woman of the Year, including sponsorship opportunities, please visit http://www.whce.net or contact Kimberly A. Read at 510-991-6748.

Genomic Health, Inc. (Nasdaq: GHDX), is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype D(R), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.


'/>"/>
SOURCE Women Health Care Executives of Northern California
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Work-Family Conflict Dogs Air Force Women After Deployment
3. Work-Family Conflict Dogs Air Force Women After Deployment
4. Antioxidant Supplements May Raise Womens Skin Cancer Risk
5. Early Weight Loss in Women Linked to Dementia
6. For Health Info, Women Often Turn to the Web
7. Smoking increases risks for head and neck cancers for men and women
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Passive smoking increases sleep disturbance among pregnant women
10. Trial to Test Gene Therapy for Angina in Women
11. Exercise and yoga improves quality of life in women with early-stage breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... ... ... The recreational use of marijuana has been legal in Colorado for over ... restrictions as to where they can smoke pot. , As Colorado’s website ... not be consumed openly or publicly.” , Given the momentum of the marijuana legalization ...
(Date:2/10/2016)... , ... February 09, 2016 , ... A new leadership ... Summer 2016. FHU President Joe Wiley made the announcement Monday night, Feb. 8, prior ... a 2003 graduate of FHU and the creator of GO! Camp, has been named ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. ... are delighted to welcome a new addition to their growing practice. Beginning this ... as a nurse practitioner performing cosmetic procedures including injectables, fillers and ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... concussion, yet the cause of injury may be one of many possible sources: ... PT Continuing Education Course , Mastering Rehab Solutions for the Complexities ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... and M 1 receptor selectivity   ... StaR® technology, which has entered clinical development as ... with dementia and schizophrenia.   --> ... technology, which has entered clinical development as a ...
(Date:2/9/2016)... -- Landauer, Inc. (NYSE: LDR ), a recognized leader ... medical physics services and high quality medical consumable accessories, ... quarter ended December 31, 2015. ... Highlights , Revenue of $36.5 million compared to ... Domestic Radiation Measurement services revenues increased 2.8% year-over-year ...
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
Breaking Medicine Technology: